Get an early start on your brand's market preparations.
With spending and staffing data for the commercialization
of 16 brands, this report analyzes early-phase resource
allocation for products of all sizes -- including niche
products with modest budgets, mid-level products balancing
their expenditures, and larger brands with blockbuster
hopes.
With an emphasis on early-phase (Pre-Clinical
through Phase II) resources, the first three chapters
of the report
break down brands' commercialization spending and headcounts into
four time segments and four spending categories:
Time Segments
- Pre-Clinical
- Phase I
- Phase II
- Phase III (data included, but analysis focuses on Pre-Clinical
to Phase II. See PharmaLaunch.com for Phase III to Post-Launch
analysis)
Spending Categories
- Brand activities
- Market research
- Thought leader development
- Advertising
Chapters four through six delve into the strategies
and processes that nine of the industry’s top companies
use to allocate resources, unite R&D and marketing early
in development, and win additional funding or staff to
support brand development and commercialization.
The report also includes discussions of the timing of
early-phase marketing activities, project management and marketing
team structures, stage gate decision making, and coordinating
early-phase marketing activities and portfolio decision making.
|
More Cutting Edge
Information Reports: |
|
 |
 |
 |